Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NeuVax + Trastuzumab in High-risk HER2+ Breast Cancer
NCT02297698Phase 2Completed
- Sponsor
- Cancer Insight
- Start
- Oct 2014
- Primary completion
- Dec 2021
- Modality
- Peptides, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nelipepimut-S in breast cancer, sponsored by Cancer Insight. Started Oct 2014; status: completed.
02
Drugs
nelipepimut-S
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT02297698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02297698.